Creates provisions relating to ibogaine treatment

HB 2817, the Veterans Mental Health Innovation Act, creates a state grant program to fund clinical trials using ibogaine for treating opioid use disorder and other mental health conditions. Eligible entities (like hospitals or research institutions within the state) must partner with a consortium that has submitted an FDA application for ibogaine trials, demonstrate relevant research experience, and match state grant funds with non-state funding. The bill establishes two dedicated state funds: an "Ibogaine Study Fund" for grant awards and an "Intellectual Property Fund" to collect revenue from trial-related patents or treatments, which will support veteran and at-risk population programs. It requires quarterly progress reports from grant recipients and annual legislative updates, with grant applications to begin accepting before November 1, 2026.